This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai Senhui Medicine Co., Ltd., Shanghai Shengdi Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jianyu Shi - Innovator in Benzazepine Compounds
Introduction
Jianyu Shi is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzazepine compounds. His research focuses on the preparation methods and pharmaceutical applications of these compounds, which are essential in treating various medical conditions.
Latest Patents
Jianyu Shi holds a patent for "Benzazepine compounds, preparation method therefor and pharmaceutical use thereof." This invention relates to a compound represented by formula II-1 or formula VIII-1, along with a pharmaceutical composition containing the same. The benzazepine compounds developed by Shi can be utilized for treating diseases associated with vasopressin receptors, specifically hypertension and heart disease. He has 1 patent to his name.
Career Highlights
Throughout his career, Jianyu Shi has worked with prominent companies in the pharmaceutical industry, including Shanghai Senhui Medicine Co., Ltd. and Shanghai Shengdi Pharmaceutical Co., Ltd. His expertise in the field has allowed him to contribute to the development of innovative medical solutions.
Collaborations
Jianyu Shi has collaborated with several professionals in his field, including Lingjian Zhu and Changjin Ji. These partnerships have further enhanced his research and development efforts in pharmaceuticals.
Conclusion
Jianyu Shi is a distinguished inventor whose work on benzazepine compounds has the potential to impact the treatment of significant health issues. His contributions to the pharmaceutical industry reflect his dedication to innovation and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile